BOTOX, Dysport, and DAXXIFY are all forms of botulinum toxin type A, but they don't behave the same way once injected. BOTOX typically shows results within three to five days and reaches full effect by about two weeks, with results lasting three to four months. Dysport tends to work faster, often visible within one to three days, and spreads more evenly across larger areas like the forehead, with results lasting three to six months. DAXXIFY, the newest option, uses a peptide-based formula that can extend results to around six months.
Modern Women's Health was founded by board-certified OB/GYN Dr. Lisa M. Jukes, an Austin Monthly Top Doctor since 2015, and built its 360-degree approach to health and beauty around that same standard of care. BOTOX and Dysport treatments here are administered by Aubrey Houchin, RN, a certified injector with more than 20 years in aesthetic medicine. In this blog, we break down how each neurotoxin works and how to figure out which one fits you best.
How BOTOX, Dysport, and DAXXIFY Differ
Every one of these neuromodulators uses a form of botulinum toxin type A, but they differ in onset, duration, and formula. Here's how they compare:
- Onset: BOTOX generally softens lines in three to five days, with full effect closer to two weeks; Dysport often shows change within one to three days; DAXXIFY results can appear within two days.
- Duration: BOTOX results generally last three to four months, Dysport can last three to six months, and DAXXIFY's peptide-based formula may extend results to around six months.
- Formulation: BOTOX and Dysport are stabilized with human serum albumin, while DAXXIFY uses a proprietary peptide and contains no animal-derived ingredients
- Spread pattern: Dysport diffuses more broadly through tissue, which can suit larger treatment areas, while BOTOX and DAXXIFY stay more concentrated at the injection site
The right option usually comes down to how a patient's muscles respond and how long they want to wait between appointments.
How Do These Neurotoxins Work?
All three work the same basic way. Once injected into a facial muscle, the toxin blocks acetylcholine, the chemical that tells the muscle to contract. Without that signal, the muscle relaxes, and lines caused by repeated movement, like squinting or frowning, begin to soften. Nerve signaling returns over time and movement comes back gradually, which is why maintenance appointments keep results consistent.
Because these treatments target muscle activity instead of skin volume, Aubrey can pair any of them with dermal fillers or microneedling for a more complete plan.
Which Neurotoxin Is Right for You?
Most healthy adults are candidates for a neuromodulator. The best fit depends on the treatment area and how often someone wants to return for touch-ups. Patients treating crow's feet may prefer Dysport's faster onset, while those hoping to stretch time between visits might lean toward a longer-lasting option.
A few factors rule a patient out regardless of which product is used:
- Pregnancy or breastfeeding
- A neuromuscular disorder such as Myasthenia Gravis
- An active skin infection at the injection site
- A known allergy to botulinum toxin, or for Dysport, a milk protein allergy
The clearest way to find the right fit is a one-on-one consultation, where facial movement and personal goals guide the recommendation.
Considering BOTOX or Dysport? Modern Women's Health Can Help
Choosing between BOTOX and Dysport comes down to your goals and your timeline, and Aubrey Houchin, RN, takes the time to walk through both during a one-on-one consultation. Backed by Modern Women's Health's comprehensive, judgment-free approach to care, every treatment plan is built around your face, not a standard dose chart. Schedule a consultation today to find the option that fits you best.
Sources
- How does Daxxify compare to Botox? | American Society of Plastic Surgeons
- Frown line Treatment Results - DAXXIFY®
This information is provided for educational purposes only and does not replace a consultation with a licensed medical provider. Outcomes, risks, and suitability vary from patient to patient.